Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice
- PMID: 22076249
- DOI: 10.1007/s10974-011-9273-6
Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice
Abstract
Hypertrophic cardiomyopathy (HCM) is characterized by asymmetric septal hypertrophy and is often caused by mutations in MYBPC3 gene encoding cardiac myosin-binding protein C. In contrast to humans, who are already affected at the heterozygous state, mouse models develop the phenotype mainly at the homozygous state. Evidence from cell culture work suggested that altered proteasome function contributes to the pathogenesis of HCM. Here we tested in two heterozygous Mybpc3-targeted mouse models whether adrenergic stress unmasks a specific cardiac phenotype and proteasome dysfunction. The first model carries a human Mybpc3 mutation (Het-KI), the second is a heterozygous Mybpc3 knock-out (Het-KO). Both models were compared to wild-type (WT) mice. Mice were treated with a combination of isoprenaline and phenylephrine (ISO/PE) or NaCl for 1 week. Whereas ISO/PE induced left ventricular hypertrophy (LVH) with increased posterior wall thickness to a similar extent in all groups, it increased septum thickness only in Het-KI and Het-KO. ISO/PE did not affect the proteasomal chymotrypsin-like activity or β5-subunit protein level in Het-KO or wild-type mice (WT). In contrast, both parameters were markedly lower in Het-KI and negatively correlated with the degree of LVH in Het-KI only. In conclusion, adrenergic stress revealed septal hypertrophy in both heterozygous mouse models of HCM, but proteasome dysfunction only in Het-KI mice, which carry a mutant allele and closely mimic human HCM. This supports the hypothesis that proteasome impairment contributes to the pathophysiology of HCM.
Similar articles
-
Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy.Pflugers Arch. 2019 May;471(5):781-793. doi: 10.1007/s00424-018-2226-9. Epub 2018 Nov 20. Pflugers Arch. 2019. PMID: 30456444 Free PMC article. Review.
-
Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.J Mol Cell Cardiol. 2013 Oct;63:189-98. doi: 10.1016/j.yjmcc.2013.07.011. Epub 2013 Jul 26. J Mol Cell Cardiol. 2013. PMID: 23896226
-
Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.J Mol Cell Cardiol. 2012 Jun;52(6):1299-307. doi: 10.1016/j.yjmcc.2012.03.009. Epub 2012 Mar 23. J Mol Cell Cardiol. 2012. PMID: 22465693 Free PMC article.
-
Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.J Mol Cell Cardiol. 2015 Feb;79:234-43. doi: 10.1016/j.yjmcc.2014.11.018. Epub 2014 Nov 25. J Mol Cell Cardiol. 2015. PMID: 25463273 Free PMC article.
-
Targeting the population for gene therapy with MYBPC3.J Mol Cell Cardiol. 2021 Jan;150:101-108. doi: 10.1016/j.yjmcc.2020.10.003. Epub 2020 Oct 11. J Mol Cell Cardiol. 2021. PMID: 33049255 Review.
Cited by
-
Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy.Pflugers Arch. 2019 May;471(5):781-793. doi: 10.1007/s00424-018-2226-9. Epub 2018 Nov 20. Pflugers Arch. 2019. PMID: 30456444 Free PMC article. Review.
-
HspB1 phosphorylation regulates its intramolecular dynamics and mechanosensitive molecular chaperone interaction with filamin C.Sci Adv. 2019 May 22;5(5):eaav8421. doi: 10.1126/sciadv.aav8421. eCollection 2019 May. Sci Adv. 2019. PMID: 31131323 Free PMC article.
-
Animal and in silico models for the study of sarcomeric cardiomyopathies.Cardiovasc Res. 2015 Apr 1;105(4):439-48. doi: 10.1093/cvr/cvv006. Epub 2015 Jan 18. Cardiovasc Res. 2015. PMID: 25600962 Free PMC article. Review.
-
Introducing a series of topical special issues of the Journal of Muscle Research and Cell Motility: MYBPC3 special issue editorial.J Muscle Res Cell Motil. 2012 May;33(1):1-3. doi: 10.1007/s10974-012-9296-7. J Muscle Res Cell Motil. 2012. PMID: 22555918 No abstract available.
-
Sarcomeric protein modification during adrenergic stress enhances cross-bridge kinetics and cardiac output.J Appl Physiol (1985). 2017 Mar 1;122(3):520-530. doi: 10.1152/japplphysiol.00306.2016. Epub 2016 Dec 1. J Appl Physiol (1985). 2017. PMID: 27909224 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials